The methylation profile of the CDKN2B promoter, a cell cycle inhibitor gene, was reduced in cells overexpressing miR‐29b that inhibits bile duct cancer progression by releasing DNMT3B‐mediated inhibition of CDKN2B expression.11 Here, DNMT3B is linked to bile duct cancer.